7 August 2017: ReNeuron Group plc (“the Company”) (AIM: RENE), a leading UK-based stem cell therapy development company, announces that its Annual Report and Accounts for the year ended 31 March 2017 and the Notice of the 2017 Annual General Meeting (“AGM”) have been sent to shareholders and are also available on the Company’s website at www.reneuron.com.

Read more…

The Annual Report and Accounts can be found under the Investors section or by clicking here.